Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/ng.730.

Title:
FOXA1 is a key determinant of estrogen receptor function and endocrine response | Nature Genetics
Description:
Jason Carroll and colleagues report that the forkhead protein FOXA1 is an important determinant of estrogen receptor binding and show that expression of FOXA1 in non–breast cancer cells is sufficient to confer estrogen receptor binding and response to endocrine treatment. Estrogen receptor-α (ER) is the key feature of most breast cancers and binding of ER to the genome correlates with expression of the Forkhead protein FOXA1 (also called HNF3α). Here we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin. Almost all ER-chromatin interactions and gene expression changes depended on the presence of FOXA1 and FOXA1 influenced genome-wide chromatin accessibility. Furthermore, we found that CTCF was an upstream negative regulator of FOXA1-chromatin interactions. In estrogen-responsive breast cancer cells, the dependency on FOXA1 for tamoxifen-ER activity was absolute; in tamoxifen-resistant cells, ER binding was independent of ligand but depended on FOXA1. Expression of FOXA1 in non-breast cancer cells can alter ER binding and function. As such, FOXA1 is a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌆 Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,797,153 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$539,300 per month
Our calculations suggest that Nature.com earns between $359,538 and $988,730 monthly online from display advertisements.

Keywords {🔍}

article, google, scholar, cas, cancer, estrogen, breast, nature, foxa, receptor, cell, expression, chromatin, binding, cells, access, content, gene, carroll, res, cookies, analysis, genome, transcription, research, privacy, data, genetics, response, lines, nat, genes, regulation, mol, human, alpha, factor, function, information, key, determinant, hurtado, holmes, rossinnes, schmidt, interactions, accessibility, rev, dev, regulatory,

Topics {✒️}

nature portfolio permissions reprints privacy policy cancer research uk enhancer-driven lineage-specific transcription cambridge research institute advertising estrogen receptor-regulated transcription ccctc-binding factor confines nature 462 nature 406 nature social media endocrine-responsive breast cancer retinoic acid receptor-alpha p130–e2f4 complexes characteristic tamoxifen-resistant mcf-7 cells discover protein-dna interactions tamoxifen-dependent gene expression tissue-specific transcription author correspondence springerlink instant access estrogen receptor alpha permissions personal data breast cancer cells breast cancer cells chromatin accessibility profiling enhanced estrogen receptor data protection breast cancer–correlation tamoxifen-resistant cells human breast tumours breast tumor subtypes estrogen receptor function androgen receptor interacts breast cancer res estrogen-er activity estrogen receptors alpha hutchison whampoa limited gene expression profiling endogenous gene expression privacy foxa1-bound enhancers upstream negative regulator competing financial interests chromosome-wide mapping tamoxifen-er activity genome-wide analysis cell cycle progression

Questions {❓}

  • Estrogen receptor null mice: what have we learned and where will they lead us?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:FOXA1 is a key determinant of estrogen receptor function and endocrine response
         description:Jason Carroll and colleagues report that the forkhead protein FOXA1 is an important determinant of estrogen receptor binding and show that expression of FOXA1 in non–breast cancer cells is sufficient to confer estrogen receptor binding and response to endocrine treatment. Estrogen receptor-α (ER) is the key feature of most breast cancers and binding of ER to the genome correlates with expression of the Forkhead protein FOXA1 (also called HNF3α). Here we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin. Almost all ER-chromatin interactions and gene expression changes depended on the presence of FOXA1 and FOXA1 influenced genome-wide chromatin accessibility. Furthermore, we found that CTCF was an upstream negative regulator of FOXA1-chromatin interactions. In estrogen-responsive breast cancer cells, the dependency on FOXA1 for tamoxifen-ER activity was absolute; in tamoxifen-resistant cells, ER binding was independent of ligand but depended on FOXA1. Expression of FOXA1 in non-breast cancer cells can alter ER binding and function. As such, FOXA1 is a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.
         datePublished:2010-12-12T00:00:00Z
         dateModified:2010-12-12T00:00:00Z
         pageStart:27
         pageEnd:33
         sameAs:https://doi.org/10.1038/ng.730
         keywords:
            Breast cancer
            Cancer genetics
            Endocrinology
            Biomedicine
            general
            Human Genetics
            Cancer Research
            Agriculture
            Gene Function
            Animal Genetics and Genomics
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig6_HTML.jpg
         isPartOf:
            name:Nature Genetics
            issn:
               1546-1718
               1061-4036
            volumeNumber:43
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Antoni Hurtado
               affiliation:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kelly A Holmes
               affiliation:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Caryn S Ross-Innes
               affiliation:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dominic Schmidt
               affiliation:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jason S Carroll
               affiliation:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                     address:
                        name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:FOXA1 is a key determinant of estrogen receptor function and endocrine response
      description:Jason Carroll and colleagues report that the forkhead protein FOXA1 is an important determinant of estrogen receptor binding and show that expression of FOXA1 in non–breast cancer cells is sufficient to confer estrogen receptor binding and response to endocrine treatment. Estrogen receptor-α (ER) is the key feature of most breast cancers and binding of ER to the genome correlates with expression of the Forkhead protein FOXA1 (also called HNF3α). Here we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin. Almost all ER-chromatin interactions and gene expression changes depended on the presence of FOXA1 and FOXA1 influenced genome-wide chromatin accessibility. Furthermore, we found that CTCF was an upstream negative regulator of FOXA1-chromatin interactions. In estrogen-responsive breast cancer cells, the dependency on FOXA1 for tamoxifen-ER activity was absolute; in tamoxifen-resistant cells, ER binding was independent of ligand but depended on FOXA1. Expression of FOXA1 in non-breast cancer cells can alter ER binding and function. As such, FOXA1 is a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.
      datePublished:2010-12-12T00:00:00Z
      dateModified:2010-12-12T00:00:00Z
      pageStart:27
      pageEnd:33
      sameAs:https://doi.org/10.1038/ng.730
      keywords:
         Breast cancer
         Cancer genetics
         Endocrinology
         Biomedicine
         general
         Human Genetics
         Cancer Research
         Agriculture
         Gene Function
         Animal Genetics and Genomics
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fng.730/MediaObjects/41588_2011_Article_BFng730_Fig6_HTML.jpg
      isPartOf:
         name:Nature Genetics
         issn:
            1546-1718
            1061-4036
         volumeNumber:43
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Antoni Hurtado
            affiliation:
                  name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kelly A Holmes
            affiliation:
                  name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Caryn S Ross-Innes
            affiliation:
                  name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dominic Schmidt
            affiliation:
                  name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jason S Carroll
            affiliation:
                  name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
                  address:
                     name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Genetics
      issn:
         1546-1718
         1061-4036
      volumeNumber:43
Organization:
      name:Nature Publishing Group US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
      address:
         name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
      address:
         name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
      address:
         name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
      address:
         name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
      address:
         name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Antoni Hurtado
      affiliation:
            name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
            address:
               name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Kelly A Holmes
      affiliation:
            name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
            address:
               name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Caryn S Ross-Innes
      affiliation:
            name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
            address:
               name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Dominic Schmidt
      affiliation:
            name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
            address:
               name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      name:Jason S Carroll
      affiliation:
            name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre
            address:
               name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
      name:Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(104)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.66s.